Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
   Poland, Moderna Working Towards Increased Flexibility Of COVID-19 Vaccine Contracts: Reuters
   
  
  
  April 25, 2022
  From Benzinga
 
   Valneva Receives More Questions From European Regulator For Its COVID-19 Vaccine, Shares Fall
   
  
  
  April 25, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 
   World's Largest Vaccine Manufacturer Stops Making COVID-19 Vaccines As 200M Doses Pile-Up: Bloomberg
   
  
  
  April 22, 2022
  From Benzinga
 
   Celsion's Formulated DNA Plasmid COVID-19 Vaccine Candidate Shows Activity Against Two Strains
   
  April 21, 2022
  Tickers 
   CLSN
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   AstraZeneca's COVID-19 Antibody Provides Protection For At Least Six Months In High-Risk Individuals
   
  
  
  April 21, 2022
  From Benzinga
 
   Codiak BioSciences's Pan Beta-Coronavirus Vaccine Shows Encouraging Action In Animal Studies
   
  April 21, 2022
  Tickers 
   CDAK
  
  
  From Benzinga
 
   Moderna Says Dual Variant COVID-19 Booster With Beta is Better Effective Against Omicron Than Current Jab
   
  April 19, 2022
  Tickers 
   MRNA
  
  
  From Benzinga
 From Benzinga
 From Benzinga
 
   Pfizer/BioNTech Fourth COVID-19 Vaccine Dose Protects Against Omicron For At Least One Month
   
  
  
  April 18, 2022
  From Benzinga
 
   Two long COVID Patients Recover After Pfizer's Therapy; Side Effects, Safety Needs To Be Assessed: Reuters
   
  April 18, 2022
  Tickers 
   PFE
  
  
  From Benzinga
 From Benzinga
 
   As Evolving Pandemic Response, Officials Shift To Personal Choice On COVID-19 Boosters, Masks: WSJ
   
  
  
  April 18, 2022
  From Benzinga
 From Benzinga
 From Benzinga
 From Benzinga
 
   Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  
  
 Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
  © 2025 FinancialContent. All rights reserved.
 
